Healthy eating guidance to ease menopause symptoms in women with overweight or obesity
Tests eating advice, on paper or in group meetings, for menopausal women with overweight.
Plain-language title generated from the registry record
Registry title: Effects of a Dietary Intervention Based on the Dietary Guidelines for the Brazilian Population on the Reduction of Menopausal Symptoms in Overweight and Obese Women
Key facts
- Where
- Porto Alegre, BrazilSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 40 to 65 who are overweight or obese, are in perimenopause or after menopause, and have menopause symptoms. It tests a diet-guidance program.
- Age
- 40 to 65 years
- Sex
- Women only
- Disease stage
- Perimenopause or postmenopause (based on clinical criteria and/or self-report), with menopause symptoms, and overweight or obese (BMI ≥ 25 kg/m²)
- Earlier treatment
- Cannot be on hormone replacement therapy or taking medicines for obesity.
Main reasons for not taking part
- Pregnancy
- Hormone replacement therapy
- Taking medicines for obesity
- Active cancer treated with chemotherapy or immunosuppressive treatment
- Cognitive impairment
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 65 years old?
Source: NCT07822230, who can take part
Where in Brazil
- Irmandade Da Santa Casa de Misericordia de Porto AlegrePorto Alegre, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Federal University of Health Science of Porto Alegre
- Trial code
- NCT07822230
- Record updated
- 29 September 2026
- Original description
The menopausal transition is associated with significant hormonal changes that negatively impact many women's quality of life. Vasomotor symptoms, sleep disturbances, mood changes, and genitourinary symptoms are frequently reported during this period. Concurrently, there is a tendency toward increased body weight and fat redistribution, specifically central fat accumulation, which raises the risk of metabolic diseases. Although hormonal therapy is effective, it is not suitable for all women, necessitating the consideration of non-pharmacological strategies as therapeutic alternatives. Scientific evidence indicates that healthy dietary patterns and weight loss are associated with reduced menopausal symptom severity.Read full original descriptionShow less
Effects of a Dietary Intervention Based on the Dietary Guidelines for the Brazilian Population on the Reduction of Menopausal Symptoms in Overweight and Obese Women
The menopausal transition is associated with significant hormonal changes that negatively impact many women's quality of life. Vasomotor symptoms, sleep disturbances, mood changes, and genitourinary symptoms are frequently reported during this period. Concurrently, there is a tendency toward increased body weight and fat redistribution, specifically central fat accumulation, which raises the risk of metabolic diseases. Although hormonal therapy is effective, it is not suitable for all women, necessitating the consideration of non-pharmacological strategies as therapeutic alternatives. Scientific evidence indicates that healthy dietary patterns and weight loss are associated with reduced menopausal symptom severity.
The objective of the research is to evaluate the effects of a dietary intervention based on the guidelines of the Dietary Guidelines for the Brazilian Population (GAPB) on the reduction of menopausal symptoms.
A randomized clinical trial will be conducted to assess whether improving dietary quality and reducing body weight contribute to alleviating menopausal symptoms. Participants will be assigned to two groups: a control group (CG) and an intervention group (IG). Both groups will receive nutritional guidance based on the GAPB; however, the CG will receive the guidelines in printed format, whereas the IG will receive them through group sessions. The study will include perimenopausal or postmenopausal women who are overweight or obese and experiencing menopausal symptoms. Validated instruments will be administered at the beginning and end of the study to assess dietary patterns, menopausal symptoms, and nutritional status.
Inclusion: Aged 40 to 65 years; In the perimenopausal or postmenopausal stage (based on clinical criteria and/or self-report); Exhibiting clinical symptoms characteristic of menopause; Diagnosed as overweight or obese (BMI ≥ 25 kg/m²); Internet access via mobile phone or computer; Agreeing to participate by signing the Informed Consent Form (ICF).
Exclusion: Undergoing hormone replacement therapy; Taking medications for obesity; Diagnosed with active neoplasms undergoing chemotherapy or immunosuppressive treatment; Cognitive impairment; Pregnancy.